CLSA announces a major expansion to its advocacy team, hiring three new government relations directors based in its Sacramento and Washington, D.C. offices, bringing its in-house advocacy staff count to 9 personnel. Oliver Rocroi has been hired as Senior Director, State Government Relations; Manny Heer has been hired as Director, Alliance Development & Advocacy; and Adam Lotspike has been hired as Associate Director, Federal Government Relations.
CLSA President & CEO Sara Radcliffe comments on the President’s proposed $6 billion cut to the National Institutes of Health (NIH) in his budget blueprint.
Larry W. Kwak and Daria Mochly-Rosen elected to CLSA Board
Legislators Honored for Commitment to Strengthening and Promoting California Life Sciences Sector
San Diego Congressman Named to U.S. House Committee Critical to Continued Success of San Diego’s Life Sciences Community.
CLSA congratulates Congresswoman Mimi Walters on her appointment to the prestigious House Energy and Commerce Committee, which holds broad authority and jurisdiction over matters that are critical to the continued success of California’s life sciences sector.
The Protect Medical Innovation Act of 2017, introduced today in the U.S. House, would permanently eliminate 2.3% excise tax on medical device manufacturers.
CLSI announced today that it will celebrate the expansion of its FAST Accelerator program to Davis and Southern California – and its designation as the West Coast accelerator for combating antimicrobial resistance (CLSI CARB-X) – at a special FAST Showcase & Reception on Dec. 13 at the Wilsey Theater and Education Studio of the War Memorial Building in San Francisco.
CLSA-endorsed bipartisan package of innovative reforms will help propel U.S. life sciences research, investment and innovation
Bipartisan package of innovative reforms will help propel U.S. life sciences research, investment and innovation.